Scarica l'app Stockscreener
2.20
2.33%
0.05
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché HRTX Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$2.15
Aprire:
$2.16
Volume 24 ore:
823.59K
Relative Volume:
0.56
Capitalizzazione di mercato:
$323.43M
Reddito:
$137.74M
Utile/perdita netta:
$-27.97M
Rapporto P/E:
-13.75
EPS:
-0.16
Flusso di cassa netto:
$-9.61M
1 W Prestazione:
+1.85%
1M Prestazione:
+10.00%
6M Prestazione:
+32.53%
1 anno Prestazione:
-20.58%
Intervallo 1D:
$2.13
$2.225
Intervallo di 1 settimana:
$2.035
$2.30
Portata 52W:
$1.04
$3.73
Heron Therapeutics Inc Stock (HRTX) Company Profile
Nome
Heron Therapeutics Inc
Settore
Industria
Telefono
(858) 251-4400
Indirizzo
4242 CAMPUS POINT COURT, SUITE 200, SAN DIEGO, CA
Confronta HRTX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
HRTX
Heron Therapeutics Inc
|
2.20 | 323.43M | 137.74M | -27.97M | -9.61M | -0.16 |
|
VRTX
Vertex Pharmaceuticals Inc
|
459.62 | 115.95B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
547.36 | 56.52B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
331.91 | 39.44B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
543.48 | 35.14B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
245.49 | 28.51B | 3.81B | -644.79M | -669.77M | -6.24 |
Heron Therapeutics Inc Stock (HRTX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-09 | Iniziato | H.C. Wainwright | Buy |
| 2024-06-13 | Iniziato | Rodman & Renshaw | Buy |
| 2024-04-23 | Iniziato | CapitalOne | Overweight |
| 2024-03-13 | Reiterato | Needham | Buy |
| 2020-05-27 | Iniziato | Guggenheim | Buy |
| 2020-02-20 | Reiterato | Needham | Buy |
| 2019-01-16 | Reiterato | Needham | Buy |
| 2018-04-05 | Iniziato | Evercore ISI | Outperform |
| 2018-03-19 | Reiterato | Mizuho | Buy |
| 2018-03-01 | Reiterato | Needham | Buy |
| 2018-01-03 | Iniziato | Leerink Partners | Outperform |
| 2017-09-27 | Iniziato | Northland Capital | Outperform |
| 2017-02-27 | Iniziato | Needham | Buy |
| 2016-10-26 | Iniziato | Aegis Capital | Buy |
| 2016-09-06 | Ripresa | Lake Street | Buy |
| 2016-05-03 | Iniziato | Cantor Fitzgerald | Buy |
| 2015-12-10 | Iniziato | Lake Street | Buy |
| 2015-09-23 | Reiterato | Leerink Partners | Outperform |
| 2015-09-02 | Iniziato | BofA/Merrill | Buy |
| 2015-08-03 | Reiterato | Brean Capital | Buy |
| 2015-06-30 | Reiterato | JMP Securities | Mkt Outperform |
| 2015-06-19 | Reiterato | Leerink Partners | Outperform |
| 2014-08-07 | Iniziato | Noble Financial | Buy |
Mostra tutto
Heron Therapeutics Inc Borsa (HRTX) Ultime notizie
Heron Therapeutics Holds Annual Stockholders Meeting - TipRanks
What is HC Wainwright's Estimate for HRTX Q2 Earnings? - MarketBeat
Heron Therapeutics, Inc. (NASDAQ:HRTX) Shares Sold by Millennium Management LLC - MarketBeat
Jane Street Group LLC Sells 284,299 Shares of Heron Therapeutics, Inc. (NASDAQ:HRTX) - MarketBeat
Heron Therapeutics (NASDAQ:HRTX) Coverage Initiated by Analysts at HC Wainwright - MarketBeat
Q2 Earnings Forecast for HRTX Issued By HC Wainwright - Defense World
Heron Therapeutics (NASDAQ:HRTX) Now Covered by Analysts at HC Wainwright - Defense World
Heron Therapeutics (HRTX) Receives "Buy" Initiation from HC Wainwright | HRTX Stock News - GuruFocus
HC Wainwright Initiates Coverage on Heron Therapeutics With Buy Rating, $6 Price Target - MarketScreener
Heron Therapeutics (HRTX) Gains Buy Rating and Positive Outlook | HRTX Stock News - GuruFocus
This Ryder System Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga
Nuveen Asset Management LLC Sells 792,421 Shares of Heron Therapeutics, Inc. (NASDAQ:HRTX) - MarketBeat
Heron Therapeutics (NASDAQ:HRTX) Raised to "Buy" at Wall Street Zen - MarketBeat
Wellington Management Group LLP Sells 8,105 Shares of Heron Therapeutics, Inc. (NASDAQ:HRTX) - Defense World
Wall Street Zen Upgrades Heron Therapeutics (NASDAQ:HRTX) to “Buy” - Defense World
Heron Therapeutics, Inc. (NASDAQ:HRTX) Stake Lessened by Two Sigma Investments LP - MarketBeat
Nuveen Asset Management LLC Reduces Holdings in Heron Therapeutics, Inc. (NASDAQ:HRTX) - Defense World
Heron Therapeutics, Inc. (NASDAQ:HRTX) Stake Raised by Bank of America Corp DE - Defense World
Heron Therapeutics, Inc. (NASDAQ:HRTX) Shares Bought by ProShare Advisors LLC - Defense World
Two Sigma Investments LP Sells 411,906 Shares of Heron Therapeutics, Inc. (NASDAQ:HRTX) - Defense World
LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Heron Therapeutics, Inc. To Contact The Firm - ACCESS Newswire
Northern Trust Corp Buys 21,769 Shares of Heron Therapeutics, Inc. (NASDAQ:HRTX) - Defense World
Heron Therapeutics (NASDAQ:HRTX) Stock Rating Lowered by Wall Street Zen - MarketBeat
3,075,809 Shares in Heron Therapeutics, Inc. (NASDAQ:HRTX) Bought by Point72 Asset Management L.P. - MarketBeat
20,000 Shares in Heron Therapeutics, Inc. (NASDAQ:HRTX) Purchased by Focus Partners Wealth - Defense World
Tang Capital Management LLC Purchases 290,271 Shares of Heron Therapeutics, Inc. (NASDAQ:HRTX) - MarketBeat
Stonepine Capital Management LLC Buys Shares of 700,000 Heron Therapeutics, Inc. (NASDAQ:HRTX) - MarketBeat
D. E. Shaw & Co. Inc. Trims Holdings in Heron Therapeutics, Inc. (NASDAQ:HRTX) - MarketBeat
Q&A with Barry Quart, CEO at Connect Biopharma - citybiz
Heron Therapeutics, Inc. (NASDAQ:HRTX) Shares Purchased by Price T Rowe Associates Inc. MD - Defense World
Raymond James Financial Inc. Buys New Holdings in Heron Therapeutics, Inc. (NASDAQ:HRTX) - MarketBeat
Bridgeway Capital Management LLC Acquires Shares of 300,000 Heron Therapeutics, Inc. (NASDAQ:HRTX) - MarketBeat
Volatility Of Heron Therapeutics Inc (HRTX) Reaches 9.24%: Make Sure To Keep Your Seat Tight! - Stocksregister
J. Goldman & Co LP Acquires Shares of 270,100 Heron Therapeutics, Inc. (NASDAQ:HRTX) - MarketBeat
What is Northland Capmk's Estimate for HRTX Q2 Earnings? - MarketBeat
Clearline Capital LP Has $2.77 Million Stock Holdings in Heron Therapeutics, Inc. (NASDAQ:HRTX) - MarketBeat
Raymond James Financial Inc. Buys Shares of 135,722 Heron Therapeutics, Inc. (NASDAQ:HRTX) - Defense World
Heron Therapeutics Inc Azioni (HRTX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.68%
0.50%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):